☆ 4.7 Article

Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation-induced profibrotic fibroblast responses

INTERNATIONAL JOURNAL OF CANCER (2022)

Related references

Note: Only part of the references are listed.

Review Chemistry, Medicinal

Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases

Ewelina Kulikowski et al.

Summary: The clinical development of BET protein inhibitors is unique, as they are being widely evaluated for treating various human diseases due to their novel mechanism of action. Among the BET protein family, BRD4 is extensively studied, and its activity at latent enhancers is a representative example of BET protein function. The role of BET proteins in embryonic development, cancer, cardiovascular, autoimmune, and metabolic diseases makes them attractive targets for therapeutic intervention.

MEDICINAL RESEARCH REVIEWS (2021)

Add to Collection

Article Chemistry, Medicinal

Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins

Yuantao Fu et al.

Summary: Dysfunction of BET family proteins is associated with various human diseases, making them promising targets for drug development. Most current clinical BET inhibitors lack selectivity, but selective inhibitors targeting BD1 and BD2 are being developed to elucidate their distinct functions.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Selectively targeting individual bromodomain: Drug discovery and molecular mechanisms

Qianqian Wang et al.

Summary: Research has shown that although bromodomain-containing proteins exhibit high structural similarity, individual bromodomains have distinct functions and can lead to different cellular phenotypes after pharmacological inhibition. Significant progress has been made in developing bromodomain-selective inhibitors targeting BET and non-BET proteins, enriching the knowledge base for bromodomain-selective drug discovery.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats

Chongxiang Xiong et al.

Summary: The small-molecule inhibitor I-BET151 effectively prevented renal dysfunction and fibrosis in rats with hyperuricemic nephropathy by inhibiting epithelial to mesenchymal transition and inflammation while blocking TGF-beta, ERK1/2, and NF-kappa B signaling pathways.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Oncology

Achieving clinical success with BET inhibitors as anti-cancer agents

Tatiana Shorstova et al.

Summary: Transcriptional upregulation of oncogenes drives tumor progression, and targeting BET proteins with inhibitors has shown promise in suppressing oncogenic networks in tumors. Understanding the biology of BET proteins, designing better BET inhibitors, and incorporating BET inhibitors into combination therapies can enhance their efficacy in clinical settings.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast Response

Chun-Shan Liu et al.

Summary: Modulation of the epigenetic pattern at the DGKA enhancer can attenuate pro-fibrotic reactions in human fibroblasts after radiotherapy, offering potential therapeutic options to prevent or reduce radiotherapy-induced fibrosis. Targeted epigenomic and genomic editing of the DGKA enhancer, as well as administration of epigenetic drugs like bromodomain inhibitors, can effectively modulate radiation-induced expression of DGKA and pro-fibrotic collagens in fibroblasts. Overall, epigenomic manipulation of DGKA expression may present novel personalized treatment options for radiotherapy-induced fibrosis.

CANCERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Fibroblasts: Origins, definitions, and functions in health and disease

Maksim Plikus et al.

Summary: Fibroblasts are diverse mesenchymal cells that play a role in tissue homeostasis and disease, producing complex extracellular matrix and creating signaling niches. They are transcriptionally and functionally heterogeneous across and within organs, encoding positional information and maintaining distinct cellular progeny. Their unique properties make them poised for tissue repair but can also drive fibrotic disorders if activated aberrantly.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

A transcriptional switch governs fibroblast activation in heart disease

Michael Alexanian et al.

Summary: In diseased organs, stress-activated signalling cascades alter chromatin, triggering maladaptive cell state transitions. Inhibition of BET proteins alleviates cardiac dysfunction and reveals a reversible transcriptional switch in fibroblasts. This study identifies MEOX1 as a central regulator of fibroblast activation associated with cardiac dysfunction, providing potential targets for treating fibrotic disease.

NATURE (2021)

Add to Collection

Article Oncology

Long-term outcome after intraoperative radiotherapy as a boost in breast cancer

Matthias Pez et al.

STRAHLENTHERAPIE UND ONKOLOGIE (2020)

Add to Collection

Article Multidisciplinary Sciences

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

Omer Gilan et al.

SCIENCE (2020)

Add to Collection

Review Oncology

Diacylglycerol Kinase Alpha in Radiation-Induced Fibrosis: Potential as a Predictive Marker or Therapeutic Target

Chun-Shan Liu et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy

Andrew Antolic et al.

JCI INSIGHT (2020)

Add to Collection

Article Medicine, Research & Experimental

Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice

Yan Y. Sanders et al.

JCI INSIGHT (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation

Shamik Mascharak et al.

TRENDS IN MOLECULAR MEDICINE (2020)

Add to Collection

Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications

Ralf Weiskirchen et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Add to Collection

Article Biochemical Research Methods

Rapid quantification of cellular proliferation and migration using ImageJ

C. Venter et al.

BIOTECHNIQUES (2019)

Add to Collection

Article Medicine, General & Internal

Radiotherapy toxicity

Dirk De Ruysscher et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Add to Collection

Article Otorhinolaryngology

Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy

Margot Baudelet et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Bromodomains: a new target class for drug development

Andrea G. Cochran et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Article Multidisciplinary Sciences

lBromodomain inhibitor JQ1 reversibly blocks IFN-γ production

Hunter R. Gibbons et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Multidisciplinary Sciences

Mapping histone modifications in low cell number and single cells using antibody-guided chromatin tagmentation (ACT-seq)

Benjamin Carter et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Article Genetics & Heredity

Identification of molecular signatures involved in radiation-induced lung fibrosis

Hee Jin et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2019)

Add to Collection

Article Multidisciplinary Sciences

The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine

Fang Xie et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Multidisciplinary Sciences

Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis

Jian Wang et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Article Oncology

BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis

Gintvile Valinciute et al.

RADIOTHERAPY AND ONCOLOGY (2017)

Add to Collection

Article Cell Biology

BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure

Qiming Duan et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Biophysics

Methods to study differences in cell mobility during skin wound healing in vitro

Hanneke N. Monsuur et al.

JOURNAL OF BIOMECHANICS (2016)

Add to Collection

Article Multidisciplinary Sciences

Epigenetic regulation of diacylglycerol kinase alpha promotes radiation-induced fibrosis

Christoph Weigel et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Multidisciplinary Sciences

BRD4 is a novel therapeutic target for liver fibrosis

Ning Ding et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Add to Collection

Article Multidisciplinary Sciences

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

Sarah Picaud et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.